These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

Lifelines Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1 Tannery House, Tannery Lane, Send, Woking, Surrey, GU23 7UF.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

At the time of approving the financial statements, the directors have assessed the Company’s ability to continue as a going concern.

In making this assessment, the directors have taken into consideration recent trading performance and prepared and reviewed detailed financial forecasts for a period of at least 12 months from the date of approval of these financial statements. These forecasts take into account expected trading performance, committed sales orders, anticipated gross margins, and overhead cost levels.

Accordingly, the directors continue to adopt the going concern basis of accounting in preparing these financial statements.

Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the sale of goods is recognised when significant risks and rewards of ownership of the goods have transferred to the buyer, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Therefore, revenue is recognised on the sales of goods when the goods are dispatched to the customer.

Revenue from the sale of services is recognised when the outcome of a transaction can be estimated reliably, revenue from servicing of products is recognised when the service is completed. If the fee is invoiced in advance, the proportion relating to post year end is treated as deferred income at the balance sheet date.

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Inventories are stated at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

The company has a specific policy in place to consider obsolete and slow moving stock. The company applies a full provision against demo stock. The policy for other stock considers when the product has last been sold and based on this analysis, the company applies a full provision against other stock that has not been sold within the last 12 months.

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including trade and other payables and loans from fellow group are recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

The tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

The average monthly number of persons (including directors) employed by the company during the year was 6 (2024 - 7).

During the year ended 31 December 2025, the Company agreed to write off an intercompany loan due from SMAG amounting to £3,369,188. The loan was voluntarily waived with no consideration received and no settlement in cash or other assets. The write-off was agreed mutually between the two parties as part of an intra-group restructuring.

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Total future financial commitments, guarantees and contingencies which are not included in the balance sheet amount to £39,000 (2024: £37,500).

This amount is in relation to operating lease commitments which are payable over the next year (2024: one year).

SMAG International Limited

During the year, SMAG International Limited owed Lifelines Limited £3,369,188 (2023: £3,290,438) in connection with an intercompany loan and accrued interest payable. Lifelines Limited is a subsidiary company of SMAG International Limited.

Interest was charged at the HMRC Average Official Rate for the year of 2.25% (2024: 2.25%) on the £3,500,000 loan facility. The loan was contractually repayable by 31 December 2034.

Interest receivable from group companies recognised during the year amounted to £78,750 (2024: £78,750).

During the year, the outstanding balance due from SMAG International Limited of £3,369,188 was written off in full under a mutual agreement by both parties, and accordingly no balance was outstanding at the reporting date.

Lifelines Neuro Company

At the year end, Lifelines Neuro Company LLC owed Lifelines Limited £2,219,539 (2024: £912,017) and was owed £745,281 (2024: £300,000) by Lifelines Limited. Of this balance consisted a loan value of £145,281 (2024: £nil) which is interest free and repayable on demand.

Synthesys Brain Health LLC (incorporated in United States of America) is regarded by the directors as being the company's ultimate parent company following a change in group structure in the year. The registered address of Synthesys Brain Health LLC is 16800 Dallas Parkway Ste, 175 Dallas, Texas, 75248, United States of America.

SMAG International Limited. (incorporated in England and Wales) is regarded by the directors as being the company's immediate parent company.

No one individual or entity has ultimate control of the company however SIDIS Corp is the single largest shareholder owning 37.7%.

The largest and smallest group within which the company belongs and for which group financial statements are prepared is headed by Synthesys Brain Health LLC.